Institutional Ownership
Springworks Therapeutics Inc
CUSIP 85205L107COMSWTXUSDQ1 2026
13D / 13G Filings
45
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
15.5%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
45 filings · latest Nov 12, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 12, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 132 | SEC |
| 2 | Aug 13, 2025 | The Goldman Sachs Group, Inc. | 13G | 11.0% | 4.23M | SEC |
| 3 | Aug 8, 2025 | Hudson Bay Capital Management LP | 13G | 5.2% | 3.94M | SEC |
| 4 | Jul 7, 2025 | Glazer Capital, LLC | 13G | — | — | SEC |
| 5 | May 7, 2025 | Fmr LLC | 13G/A | 1.7% | 1.26M | SEC |
| 6 | Feb 14, 2025 | Deep Track Capital, LP | 13G/A | 4.7% | 3.46M | SEC |
| 7 | Jan 31, 2025 | The Vanguard Group | 13G/A | 9.6% | 7.16M | SEC |
| 8 | Oct 25, 2024 | Boxer Capital Management, LLC | 13G/A | — | — | SEC |
| 9 | Feb 14, 2024 | Deep Track Capital, LP | 13G/A | 5.5% | 4.06M | SEC |
| 10 | Feb 14, 2024 | Ecor1 Capital, LLC | 13G/A | — | — | SEC |
35 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Springworks Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $47 |